Jane Street’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $13.5M | Buy |
545,227
+278,974
| +105% | +$6.65M | ﹤0.01% | 2175 |
|
|
2025
Q4 | $6.21M | Buy |
266,253
+127,157
| +91% | +$2.83M | ﹤0.01% | 2920 |
|
|
2025
Q3 | $2.74M | Sell |
139,096
-4,742
| -3% | -$97.5K | ﹤0.01% | 4383 |
|
|
2025
Q2 | $3.12M | Sell |
143,838
-139,366
| -49% | -$3.29M | ﹤0.01% | 3698 |
|
|
2025
Q1 | $6.87M | Buy |
283,204
+245,953
| +660% | +$5.54M | ﹤0.01% | 2454 |
|
|
2024
Q4 | $777K | Sell |
37,251
-364,657
| -91% | -$7.83M | ﹤0.01% | 5858 |
|
|
2024
Q3 | $7.99M | Buy |
401,908
+285,564
| +245% | +$5.29M | ﹤0.01% | 2168 |
|
|
2024
Q2 | $1.8M | Buy |
116,344
+52,989
| +84% | +$825K | ﹤0.01% | 4669 |
|
|
2024
Q1 | $1.01M | Sell |
63,355
-29,127
| -31% | -$439K | ﹤0.01% | 5394 |
|
|
2023
Q4 | $1.55M | Sell |
92,482
-84,835
| -48% | -$1.16M | ﹤0.01% | 4767 |
|
|
2023
Q3 | $2.07M | Buy |
177,317
+85,911
| +94% | +$1.15M | ﹤0.01% | 4006 |
|
|
2023
Q2 | $1.23M | Sell |
91,406
-11,062
| -11% | -$159K | ﹤0.01% | 4881 |
|
|
2023
Q1 | $1.7M | Buy |
102,468
+59,171
| +137% | +$976K | ﹤0.01% | 4106 |
|
|
2022
Q4 | $805K | Buy |
43,297
+30,127
| +229% | +$464K | ﹤0.01% | 5324 |
|
|
2022
Q3 | $169K | Sell |
13,170
-10,975
| -45% | -$130K | ﹤0.01% | 8315 |
|
|
2022
Q2 | $169K | Sell |
24,145
-51,125
| -68% | -$375K | ﹤0.01% | 8315 |
|
|
2022
Q1 | $624K | Buy |
75,270
+57,637
| +327% | +$407K | ﹤0.01% | 7063 |
|
|
2021
Q4 | $119K | Sell |
17,633
-7,691
| -30% | -$50.6K | ﹤0.01% | 9143 |
|
|
2021
Q3 | $134K | Buy |
25,324
+4,312
| +21% | +$23.6K | ﹤0.01% | 9131 |
|
|
2021
Q2 | $121K | Buy |
+21,012
| New | +$108K | ﹤0.01% | 9170 |
|
|
2021
Q1 | – | Sell |
-32,654
| Closed | -$109K | – | 9139 |
|
|
2020
Q4 | $109K | Sell |
32,654
-132,048
| -80% | -$444K | ﹤0.01% | 7182 |
|
|
2020
Q3 | $489K | Buy |
164,702
+150,741
| +1,080% | +$589K | ﹤0.01% | 5183 |
|
|
2020
Q2 | $65K | Buy |
+13,961
| New | +$62.7K | ﹤0.01% | 6812 |
|
|
2019
Q4 | – | Sell |
-24,776
| Closed | -$132K | – | 5125 |
|
|
2019
Q3 | $132K | Buy |
+24,776
| New | +$132K | ﹤0.01% | 4745 |
|
|
2018
Q1 | – | Sell |
-18,720
| Closed | -$73K | – | 4865 |
|
|
2017
Q4 | $73K | Sell |
18,720
-5,279
| -22% | -$17.4K | ﹤0.01% | 4380 |
|
|
2017
Q3 | $60K | Buy |
+23,999
| New | +$65.8K | ﹤0.01% | 4323 |
|
|
2016
Q3 | – | Sell |
-65,594
| Closed | -$47K | – | 4045 |
|
|
2016
Q2 | $47K | Buy |
+65,594
| New | +$52.8K | ﹤0.01% | 3961 |
|
|
2014
Q4 | – | Sell |
-46,039
| Closed | -$153K | – | 2538 |
|
|
2014
Q3 | $153K | Buy |
+46,039
| New | +$120K | ﹤0.01% | 2290 |
|
|
2014
Q1 | – | Sell |
-42,460
| Closed | -$83K | – | 2706 |
|
|
2013
Q4 | $83K | Sell |
42,460
-5,688
| -12% | -$11.5K | ﹤0.01% | 2204 |
|
|
2013
Q3 | $147K | Buy |
+48,148
| New | +$81K | ﹤0.01% | 2485 |
|
Other funds holding CPRX
VCM
DM
VPM
Jane Street's CPRX Position: Q1 2026 in Review
Jane Street increased its Catalyst Pharmaceutical (CPRX) stake by 105% in Q1 2026, buying an estimated $6.65M and bringing the position to 545,227 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2175.
Jane Street first reported a position in CPRX in Q3 2013 and has held it in 30 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Jane Street held 545,227 shares of Catalyst Pharmaceutical worth $13.5M as of Q1 2026.
- Jane Street bought 278,974 Catalyst Pharmaceutical shares in Q1 2026, an estimated $6.65M.
- Catalyst Pharmaceutical made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2175 holding.
- Jane Street first reported a position in Catalyst Pharmaceutical in Q3 2013 and has held it in 30 quarters since.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.